2018-2023 Global Antidiabetic Drug Consumption Market Report

June 2018 | 167 pages | ID: 2E9FF4C9D2FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Antidiabetic Drug market for 2018-2023.

Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.

Over the next five years, LPI(LP Information) projects that Antidiabetic Drug will register a 9.0% CAGR in terms of revenue, reach US$ 76300 million by 2023, from US$ 49600 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Antidiabetic Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Alpha-Glucosidase Inhibitors
• Biguanides, Sulphonylureas
• Glp-1 Agonist
• Meglitinides
• Dpp-4 Inhibitors
• Sglt–2
• Thiazolodinediones

Segmentation by application:

• Type I Diabetes
• Type II Diabetes

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Sanofi-Aventis
• Eli Lilly
• Oramed
• Takeda
• Boehringer Ingelheim
• Novo Nordisk
• Halozyme Therapeutics
• Bristol-Myers Squibb
• Pfizer
• Tonghua Dongbao
• Biocon
• Wockhardt

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Antidiabetic Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Antidiabetic Drug market by identifying its various subsegments.
• Focuses on the key global Antidiabetic Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Antidiabetic Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Antidiabetic Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antidiabetic Drug Consumption 2013-2023
  2.1.2 Antidiabetic Drug Consumption CAGR by Region
2.2 Antidiabetic Drug Segment by Type
  2.2.1 Alpha-Glucosidase Inhibitors
  2.2.2 Biguanides, Sulphonylureas
  2.2.3 Glp-1 Agonist
  2.2.4 Meglitinides
  2.2.5 Dpp-4 Inhibitors
  2.2.6 Sglt–2
  2.2.7 Thiazolodinediones
2.3 Antidiabetic Drug Consumption by Type
  2.3.1 Global Antidiabetic Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Antidiabetic Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Antidiabetic Drug Sale Price by Type (2013-2018)
2.4 Antidiabetic Drug Segment by Application
  2.4.1 Type I Diabetes
  2.4.2 Type II Diabetes
2.5 Antidiabetic Drug Consumption by Application
  2.5.1 Global Antidiabetic Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Antidiabetic Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Antidiabetic Drug Sale Price by Application (2013-2018)

3 GLOBAL ANTIDIABETIC DRUG BY PLAYERS

3.1 Global Antidiabetic Drug Sales Market Share by Players
  3.1.1 Global Antidiabetic Drug Sales by Players (2016-2018)
  3.1.2 Global Antidiabetic Drug Sales Market Share by Players (2016-2018)
3.2 Global Antidiabetic Drug Revenue Market Share by Players
  3.2.1 Global Antidiabetic Drug Revenue by Players (2016-2018)
  3.2.2 Global Antidiabetic Drug Revenue Market Share by Players (2016-2018)
3.3 Global Antidiabetic Drug Sale Price by Players
3.4 Global Antidiabetic Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Antidiabetic Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Antidiabetic Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ANTIDIABETIC DRUG BY REGIONS

4.1 Antidiabetic Drug by Regions
  4.1.1 Global Antidiabetic Drug Consumption by Regions
  4.1.2 Global Antidiabetic Drug Value by Regions
4.2 Americas Antidiabetic Drug Consumption Growth
4.3 APAC Antidiabetic Drug Consumption Growth
4.4 Europe Antidiabetic Drug Consumption Growth
4.5 Middle East & Africa Antidiabetic Drug Consumption Growth

5 AMERICAS

5.1 Americas Antidiabetic Drug Consumption by Countries
  5.1.1 Americas Antidiabetic Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Antidiabetic Drug Value by Countries (2013-2018)
5.2 Americas Antidiabetic Drug Consumption by Type
5.3 Americas Antidiabetic Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Antidiabetic Drug Consumption by Countries
  6.1.1 APAC Antidiabetic Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Antidiabetic Drug Value by Countries (2013-2018)
6.2 APAC Antidiabetic Drug Consumption by Type
6.3 APAC Antidiabetic Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Antidiabetic Drug by Countries
  7.1.1 Europe Antidiabetic Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Antidiabetic Drug Value by Countries (2013-2018)
7.2 Europe Antidiabetic Drug Consumption by Type
7.3 Europe Antidiabetic Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antidiabetic Drug by Countries
  8.1.1 Middle East & Africa Antidiabetic Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Antidiabetic Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Antidiabetic Drug Consumption by Type
8.3 Middle East & Africa Antidiabetic Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Antidiabetic Drug Distributors
10.3 Antidiabetic Drug Customer

11 GLOBAL ANTIDIABETIC DRUG MARKET FORECAST

11.1 Global Antidiabetic Drug Consumption Forecast (2018-2023)
11.2 Global Antidiabetic Drug Forecast by Regions
  11.2.1 Global Antidiabetic Drug Forecast by Regions (2018-2023)
  11.2.2 Global Antidiabetic Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Antidiabetic Drug Forecast by Type
11.8 Global Antidiabetic Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Sanofi-Aventis
  12.1.1 Company Details
  12.1.2 Antidiabetic Drug Product Offered
  12.1.3 Sanofi-Aventis Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Sanofi-Aventis News
12.2 Eli Lilly
  12.2.1 Company Details
  12.2.2 Antidiabetic Drug Product Offered
  12.2.3 Eli Lilly Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Eli Lilly News
12.3 Oramed
  12.3.1 Company Details
  12.3.2 Antidiabetic Drug Product Offered
  12.3.3 Oramed Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Oramed News
12.4 Takeda
  12.4.1 Company Details
  12.4.2 Antidiabetic Drug Product Offered
  12.4.3 Takeda Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Takeda News
12.5 Boehringer Ingelheim
  12.5.1 Company Details
  12.5.2 Antidiabetic Drug Product Offered
  12.5.3 Boehringer Ingelheim Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Boehringer Ingelheim News
12.6 Novo Nordisk
  12.6.1 Company Details
  12.6.2 Antidiabetic Drug Product Offered
  12.6.3 Novo Nordisk Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Novo Nordisk News
12.7 Halozyme Therapeutics
  12.7.1 Company Details
  12.7.2 Antidiabetic Drug Product Offered
  12.7.3 Halozyme Therapeutics Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Halozyme Therapeutics News
12.8 Bristol-Myers Squibb
  12.8.1 Company Details
  12.8.2 Antidiabetic Drug Product Offered
  12.8.3 Bristol-Myers Squibb Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Bristol-Myers Squibb News
12.9 Pfizer
  12.9.1 Company Details
  12.9.2 Antidiabetic Drug Product Offered
  12.9.3 Pfizer Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Pfizer News
12.10 Tonghua Dongbao
  12.10.1 Company Details
  12.10.2 Antidiabetic Drug Product Offered
  12.10.3 Tonghua Dongbao Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Tonghua Dongbao News
12.11 Biocon
12.12 Wockhardt

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic Drug
Table Product Specifications of Antidiabetic Drug
Figure Antidiabetic Drug Report Years Considered
Figure Market Research Methodology
Figure Global Antidiabetic Drug Consumption Growth Rate 2013-2023 (K MT)
Figure Global Antidiabetic Drug Value Growth Rate 2013-2023 ($ Millions)
Table Antidiabetic Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Alpha-Glucosidase Inhibitors
Table Major Players of Alpha-Glucosidase Inhibitors
Figure Product Picture of Biguanides, Sulphonylureas
Table Major Players of Biguanides, Sulphonylureas
Figure Product Picture of Glp-1 Agonist
Table Major Players of Glp-1 Agonist
Figure Product Picture of Meglitinides
Table Major Players of Meglitinides
Figure Product Picture of Dpp-4 Inhibitors
Table Major Players of Dpp-4 Inhibitors
Figure Product Picture of Sglt–2
Table Major Players of Sglt–2
Figure Product Picture of Thiazolodinediones
Table Major Players of Thiazolodinediones
Table Global Consumption Sales by Type (2013-2018)
Table Global Antidiabetic Drug Consumption Market Share by Type (2013-2018)
Figure Global Antidiabetic Drug Consumption Market Share by Type (2013-2018)
Table Global Antidiabetic Drug Revenue by Type (2013-2018) ($ million)
Table Global Antidiabetic Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Antidiabetic Drug Value Market Share by Type (2013-2018)
Table Global Antidiabetic Drug Sale Price by Type (2013-2018)
Figure Antidiabetic Drug Consumed in Type I Diabetes
Figure Global Antidiabetic Drug Market: Type I Diabetes (2013-2018) (K MT)
Figure Global Antidiabetic Drug Market: Type I Diabetes (2013-2018) ($ Millions)
Figure Global Type I Diabetes YoY Growth ($ Millions)
Figure Antidiabetic Drug Consumed in Type II Diabetes
Figure Global Antidiabetic Drug Market: Type II Diabetes (2013-2018) (K MT)
Figure Global Antidiabetic Drug Market: Type II Diabetes (2013-2018) ($ Millions)
Figure Global Type II Diabetes YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Antidiabetic Drug Consumption Market Share by Application (2013-2018)
Figure Global Antidiabetic Drug Consumption Market Share by Application (2013-2018)
Table Global Antidiabetic Drug Value by Application (2013-2018)
Table Global Antidiabetic Drug Value Market Share by Application (2013-2018)
Figure Global Antidiabetic Drug Value Market Share by Application (2013-2018)
Table Global Antidiabetic Drug Sale Price by Application (2013-2018)
Table Global Antidiabetic Drug Sales by Players (2016-2018) (K MT)
Table Global Antidiabetic Drug Sales Market Share by Players (2016-2018)
Figure Global Antidiabetic Drug Sales Market Share by Players in 2016
Figure Global Antidiabetic Drug Sales Market Share by Players in 2017
Table Global Antidiabetic Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Antidiabetic Drug Revenue Market Share by Players (2016-2018)
Figure Global Antidiabetic Drug Revenue Market Share by Players in 2016
Figure Global Antidiabetic Drug Revenue Market Share by Players in 2017
Table Global Antidiabetic Drug Sale Price by Players (2016-2018)
Figure Global Antidiabetic Drug Sale Price by Players in 2017
Table Global Antidiabetic Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Antidiabetic Drug Products Offered
Table Antidiabetic Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Antidiabetic Drug Consumption by Regions 2013-2018 (K MT)
Table Global Antidiabetic Drug Consumption Market Share by Regions 2013-2018
Figure Global Antidiabetic Drug Consumption Market Share by Regions 2013-2018
Table Global Antidiabetic Drug Value by Regions 2013-2018 ($ Millions)
Table Global Antidiabetic Drug Value Market Share by Regions 2013-2018
Figure Global Antidiabetic Drug Value Market Share by Regions 2013-2018
Figure Americas Antidiabetic Drug Consumption 2013-2018 (K MT)
Figure Americas Antidiabetic Drug Value 2013-2018 ($ Millions)
Figure APAC Antidiabetic Drug Consumption 2013-2018 (K MT)
Figure APAC Antidiabetic Drug Value 2013-2018 ($ Millions)
Figure Europe Antidiabetic Drug Consumption 2013-2018 (K MT)
Figure Europe Antidiabetic Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Antidiabetic Drug Consumption 2013-2018 (K MT)
Figure Middle East & Africa Antidiabetic Drug Value 2013-2018 ($ Millions)
Table Americas Antidiabetic Drug Consumption by Countries (2013-2018) (K MT)
Table Americas Antidiabetic Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Antidiabetic Drug Consumption Market Share by Countries in 2017
Table Americas Antidiabetic Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Antidiabetic Drug Value Market Share by Countries (2013-2018)
Figure Americas Antidiabetic Drug Value Market Share by Countries in 2017
Table Americas Antidiabetic Drug Consumption by Type (2013-2018) (K MT)
Table Americas Antidiabetic Drug Consumption Market Share by Type (2013-2018)
Figure Americas Antidiabetic Drug Consumption Market Share by Type in 2017
Table Americas Antidiabetic Drug Consumption by Application (2013-2018) (K MT)
Table Americas Antidiabetic Drug Consumption Market Share by Application (2013-2018)
Figure Americas Antidiabetic Drug Consumption Market Share by Application in 2017
Figure United States Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure United States Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Canada Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Mexico Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Table APAC Antidiabetic Drug Consumption by Countries (2013-2018) (K MT)
Table APAC Antidiabetic Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Antidiabetic Drug Consumption Market Share by Countries in 2017
Table APAC Antidiabetic Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Antidiabetic Drug Value Market Share by Countries (2013-2018)
Figure APAC Antidiabetic Drug Value Market Share by Countries in 2017
Table APAC Antidiabetic Drug Consumption by Type (2013-2018) (K MT)
Table APAC Antidiabetic Drug Consumption Market Share by Type (2013-2018)
Figure APAC Antidiabetic Drug Consumption Market Share by Type in 2017
Table APAC Antidiabetic Drug Consumption by Application (2013-2018) (K MT)
Table APAC Antidiabetic Drug Consumption Market Share by Application (2013-2018)
Figure APAC Antidiabetic Drug Consumption Market Share by Application in 2017
Figure China Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure China Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Japan Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Korea Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Southeast Asia Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure India Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure India Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Australia Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Table Europe Antidiabetic Drug Consumption by Countries (2013-2018) (K MT)
Table Europe Antidiabetic Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Antidiabetic Drug Consumption Market Share by Countries in 2017
Table Europe Antidiabetic Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Antidiabetic Drug Value Market Share by Countries (2013-2018)
Figure Europe Antidiabetic Drug Value Market Share by Countries in 2017
Table Europe Antidiabetic Drug Consumption by Type (2013-2018) (K MT)
Table Europe Antidiabetic Drug Consumption Market Share by Type (2013-2018)
Figure Europe Antidiabetic Drug Consumption Market Share by Type in 2017
Table Europe Antidiabetic Drug Consumption by Application (2013-2018) (K MT)
Table Europe Antidiabetic Drug Consumption Market Share by Application (2013-2018)
Figure Europe Antidiabetic Drug Consumption Market Share by Application in 2017
Figure Germany Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Germany Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure France Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure France Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure UK Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure UK Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Italy Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Russia Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Spain Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Antidiabetic Drug Consumption by Countries (2013-2018) (K MT)
Table Middle East & Africa Antidiabetic Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Antidiabetic Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Antidiabetic Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Antidiabetic Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Antidiabetic Drug Value Market Share by Countries in 2017
Table Middle East & Africa Antidiabetic Drug Consumption by Type (2013-2018) (K MT)
Table Middle East & Africa Antidiabetic Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Antidiabetic Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Antidiabetic Drug Consumption by Application (2013-2018) (K MT)
Table Middle East & Africa Antidiabetic Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Antidiabetic Drug Consumption Market Share by Application in 2017
Figure Egypt Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Egypt Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure South Africa Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Israel Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure Turkey Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Antidiabetic Drug Consumption Growth 2013-2018 (K MT)
Figure GCC Countries Antidiabetic Drug Value Growth 2013-2018 ($ Millions)
Table Antidiabetic Drug Distributors List
Table Antidiabetic Drug Customer List
Figure Global Antidiabetic Drug Consumption Growth Rate Forecast (2018-2023) (K MT)
Figure Global Antidiabetic Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Antidiabetic Drug Consumption Forecast by Countries (2018-2023) (K MT)
Table Global Antidiabetic Drug Consumption Market Forecast by Regions
Table Global Antidiabetic Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Antidiabetic Drug Value Market Share Forecast by Regions
Figure Americas Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Americas Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure APAC Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure APAC Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Europe Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Europe Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Middle East & Africa Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure United States Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure United States Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Canada Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Canada Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Mexico Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Mexico Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Brazil Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Brazil Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure China Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure China Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Japan Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Japan Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Korea Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Korea Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Southeast Asia Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure India Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure India Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Australia Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Australia Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Germany Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Germany Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure France Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure France Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure UK Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure UK Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Italy Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Italy Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Russia Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Russia Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Spain Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Spain Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Egypt Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Egypt Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure South Africa Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure South Africa Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Israel Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Israel Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure Turkey Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure Turkey Antidiabetic Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Antidiabetic Drug Consumption 2018-2023 (K MT)
Figure GCC Countries Antidiabetic Drug Value 2018-2023 ($ Millions)
Table Global Antidiabetic Drug Consumption Forecast by Type (2018-2023) (K MT)
Table Global Antidiabetic Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Antidiabetic Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Antidiabetic Drug Value Market Share Forecast by Type (2018-2023)
Table Global Antidiabetic Drug Consumption Forecast by Application (2018-2023) (K MT)
Table Global Antidiabetic Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Antidiabetic Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Antidiabetic Drug Value Market Share Forecast by Application (2018-2023)
Table Sanofi-Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi-Aventis Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi-Aventis Antidiabetic Drug Market Share (2016-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Eli Lilly Antidiabetic Drug Market Share (2016-2018)
Table Oramed Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Oramed Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Oramed Antidiabetic Drug Market Share (2016-2018)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Takeda Antidiabetic Drug Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Antidiabetic Drug Market Share (2016-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novo Nordisk Antidiabetic Drug Market Share (2016-2018)
Table Halozyme Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Halozyme Therapeutics Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Halozyme Therapeutics Antidiabetic Drug Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Antidiabetic Drug Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Antidiabetic Drug Market Share (2016-2018)
Table Tonghua Dongbao Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tonghua Dongbao Antidiabetic Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Tonghua Dongbao Antidiabetic Drug Market Share (2016-2018)
Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors